Nathalia Cardoso Oliveira, Fanilda S Barros, Joana Storino, Jubiza Pusic, Chantal Agüero Wagner, Fanny R Santos, Patrícia Henriques Lyra
{"title":"International ultrasound protocol for the diagnostic evaluation of lipedema: anatomical, fascial and microvascular criteria.","authors":"Nathalia Cardoso Oliveira, Fanilda S Barros, Joana Storino, Jubiza Pusic, Chantal Agüero Wagner, Fanny R Santos, Patrícia Henriques Lyra","doi":"10.23736/S0392-9590.26.05571-9","DOIUrl":"https://doi.org/10.23736/S0392-9590.26.05571-9","url":null,"abstract":"<p><strong>Background: </strong>Lipedema is a chronic disorder of adipose and loose connective tissue characterized by a symmetrical and disproportionate fat distribution, predominantly affecting women. Despite increasing recognition, the lack of a standardized and reproducible imaging protocol limits objective diagnosis, differentiation from related conditions, and comparability across centers. Ultrasonography represents an accessible and versatile tool for evaluating subcutaneous tissue, fascial structures, and microcirculation in lipedema.</p><p><strong>Methods: </strong>We developed an international, multidisciplinary, expert-based ultrasound protocol using a structured methodological framework. The protocol integrates standardized anatomical measurement points for the lower limbs (A-D) and upper limbs (1-6), quantitative assessment of subcutaneous thickness using validated cutoff values, qualitative evaluation of tissue architecture, and systematic analysis of superficial and deep fasciae. High-sensitivity Doppler techniques, including Micro Flow Imaging, were incorporated to assess microvascular patterns. Histological correlations were derived from previously published data from the authors' group, supporting the interpretation of microvascular and structural findings. The protocol was constructed through integration of current literature and expert clinical experience from a multidisciplinary international group. A structured worksheet was designed to support standardized clinical and imaging data collection.</p><p><strong>Results: </strong>The proposed protocol enables consistent identification of lipedema-related ultrasonographic features, including increased subcutaneous thickness, septal disorganization, nodularity, fascial thickening, reduced fascial gliding, and low-resistance microvascular flow. The use of standardized measurement points and cutoff values enhances reproducibility and supports differentiation from lymphedema, edema, obesity, and lipohypertrophy. By integrating quantitative, qualitative, and functional parameters, the protocol addresses current limitations of purely qualitative ultrasound classifications. The worksheet and cartographic approach allow systematic bilateral documentation and facilitate multicenter comparability.</p><p><strong>Conclusions: </strong>This international ultrasound protocol provides a comprehensive and standardized approach for the diagnostic assessment of lipedema, integrating subcutaneous, fascial, and microvascular parameters. It should be interpreted as an expert-informed framework intended to improve diagnostic consistency and to support future prospective validation studies. Its application may improve diagnostic accuracy, promote multicenter research, and support longitudinal monitoring and therapeutic decision-making.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149386490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Association of modified cardiovascular health with long-term all-cause mortality among adults with Ankle-Brachial Index-defined peripheral artery disease: a NHANES 1999-2004 cohort study.","authors":"Mingxiu Wang, Yong Wang","doi":"10.23736/S0392-9590.26.05601-4","DOIUrl":"https://doi.org/10.23736/S0392-9590.26.05601-4","url":null,"abstract":"<p><strong>Background: </strong>Whether an integrated cardiovascular health profile is associated with long-term mortality among adults with objectively defined peripheral artery disease (PAD) remains insufficiently characterized in nationally representative cohorts.</p><p><strong>Methods: </strong>We analyzed National Health and Nutrition Examination Survey (NHANES) 1999-2004 participants aged ≥40 years with Ankle-Brachial Index (ABI) measurements and linked mortality follow-up through December 31, 2019. PAD was defined as a minimum ABI ≤0.90. Modified cardiovascular health (mCVH; range 0-12) was constructed from smoking, Body Mass Index, physical activity, blood pressure, total cholesterol, and glycemic status. Corrected six-year Mobile Examination Center weights and complex survey design variables were used. Weighted Cox models estimated hazard ratios (HRs) for all-cause mortality using sequential adjustment for demographic factors, socioeconomic factors, survey cycle, and minimum ABI. Additional analyses evaluated non-PAD participants and cardiovascular mortality.</p><p><strong>Results: </strong>The primary PAD cohort included 554 adults, among whom 428 deaths occurred during a median follow-up of 123.5 months. PAD participants had a higher absolute all-cause mortality burden than non-PAD participants. Each 1-point higher mCVH score was associated with lower all-cause mortality in Model 1 (HR 0.888, 95% CI 0.842-0.937; P<0.001), Model 2 (HR 0.922, 95% CI 0.870-0.977; P=0.006), and Model 3 (HR 0.926, 95% CI 0.874-0.982; P=0.010). Among non-PAD participants, higher mCVH was also associated with lower all-cause mortality, and the mCVH × PAD status interaction was not statistically significant (P=0.122). In sensitivity analysis, higher mCVH was also associated with lower cardiovascular mortality (HR 0.863, 95% CI 0.786-0.948; P=0.002). Component-level analyses suggested that smoking was the most robust individual component.</p><p><strong>Conclusions: </strong>Among U.S. adults with ABI-defined PAD, higher baseline mCVH was associated with lower long-term all-cause mortality. These findings support the prognostic relevance of integrated cardiovascular health profiling after objective PAD identification, while highlighting smoking as the most consistent individual component.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149297343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Foteini Psachoulia, Christos Karathanos, Constantine Antonopoulos, Dimitrios Kardoulas, Georgios Sfyroeras, Christina Chania, Aikaterini Argyropoulou, Eleni-Vaskani Mikropoulou, Alexios Leandros Skaltsounis, Ioannis Kakisis, Athanasios Giannoukas, Ioanna Andreadou, George Geroulakos
{"title":"Vitis vinifera leaf extract improves quality-of-life and significantly decreases IL-6 levels in patients with chronic venous disease: a prospective, randomized, double-blind, placebo-controlled study.","authors":"Foteini Psachoulia, Christos Karathanos, Constantine Antonopoulos, Dimitrios Kardoulas, Georgios Sfyroeras, Christina Chania, Aikaterini Argyropoulou, Eleni-Vaskani Mikropoulou, Alexios Leandros Skaltsounis, Ioannis Kakisis, Athanasios Giannoukas, Ioanna Andreadou, George Geroulakos","doi":"10.23736/S0392-9590.26.05549-5","DOIUrl":"https://doi.org/10.23736/S0392-9590.26.05549-5","url":null,"abstract":"<p><strong>Background: </strong>Phlebotonic medication is an established conservative management approach for Chronic Venous Disease (CVD). This study evaluates whether a new formulation of red vine leaf-containing supplement relieves symptoms, improves quality-of-life and affects oxidative stress and inflammation in C2-C3 CVD patients.</p><p><strong>Methods: </strong>This prospective, multicenter, randomized, double-blind, placebo-controlled study enrolled 58 participants, allocated 1:1 to self-administer the Vitis vinifera supplement (N.=30) or placebo (N.=28), orally for 8 weeks. Assessments were conducted at baseline and post-intervention. Primary endpoints included changes in clinical symptomatology (Visual Analogue Scale/VAS), leg oedema and calf veins diameter. Secondary outcomes assessed quality-of-life (CIVIQ-20), biomarkers of oxidative stress (malondialdehyde/MDA, protein carbonyls/PCs), inflammation (C-Reactive Protein/CRP, Interleukin-6/IL-6) and endothelial function (Cyclic Guanosine Monophosphate/cGMP) and adverse events incidence. Data analysis was conducted using SPSS and GraphPad Prism.</p><p><strong>Results: </strong>Mean age was 55.4±11.1 years in the intervention group and 56.2±14.4 in the placebo (P=0.82). Post-treatment, numbness/tingling VAS score significantly reduced in the intervention group compared to placebo (3±3.4 versus 1.33±2.7 points; P=0.040). CIVIQ-20 score reduction was also significantly greater (15.9±14 versus 5.9±15.1; P=0.011). At baseline, there were no significant differences between the V. vinifera supplement and placebo groups in mean ankle or calf circumference. After 8 weeks, both parameters remained comparable between groups. IL-6 levels were significantly reduced in the intervention group to 80.82±8.27pg/mL (baseline 114.7±8.87 pg/mL; P=0.015), whereas the placebo showed a non-significant marginal increase to 103.7±13.55 pg/mL (baseline 89.91±9.2 pg/mL; P=0.41).</p><p><strong>Conclusions: </strong>We demonstrate that the V. vinifera-derived supplement reduces numbness/tingling and improves quality-of-life in C2-C3 CVD patients, potentially through inflammatory biomarkers modulation.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149297254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kosmas I Paraskevas, Michael S Conte, Francesco Spinelli, Alik Farber, Matthew Blecha, Mahmoud B Malas, Alan Dardik, Bruce A Perler, Salvatore Scali, E Sebastian Debus, Thomas Zeller, Christopher J Abularrage, Giovanni B Torsello, Nabil Chakfe, John V White, Jos C VAN DEN Berg, Clark J Zeebregts, Nicola Troisi, Melina Vega DE Ceniga, Francesco Stilo, Mario D'Oria, Meghan Dermody, Piotr Myrcka, Katariina M Noronen, Jean-Baptiste Ricco, Hany Zayed, Michel J Bosiers, Robert A Morgan, Bruno Migliara, Caitlin W Hicks, Sherif A Sultan, Eric A Secemsky, Armando Mansilha, Michel M Reijnen, Hence J Verhagen, Mauro Gargiulo, Gianluca Faggioli, Guillaume Goudot, Domenico Valenti, Christian-Alexander Behrendt, Carlo Setacci, Alexei Svetlikov, Felice Pecoraro, Theodosios Bisdas, Andrej Schmidt, Arkadiusz Jawien, Csaba Csobay-Novak, Frank E Vermassen, Riikka Tulamo, Zoltan Szeberin, Bruce H Gray, Alessia Giaquinta, Jose Fernandes E Fernandes, Christos D Liapis, Vlad A Alexandrescu, Gaetano Lanza, Nuno V Dias, Diogo Cunha E Sa, Kak K Yeung, Piotr Musialek, Goncalo Cabral, Erwin Blessing, Gabor Menyhei, Robert C Lind, Ali Aburahma, Sean P Lyden, Marc L Schermerhorn, Frank J Veith
{"title":"A Trans-Atlantic, Expert-Based, Delphi Consensus Document on controversial issues in the management of patients with chronic limb-threatening ischemia.","authors":"Kosmas I Paraskevas, Michael S Conte, Francesco Spinelli, Alik Farber, Matthew Blecha, Mahmoud B Malas, Alan Dardik, Bruce A Perler, Salvatore Scali, E Sebastian Debus, Thomas Zeller, Christopher J Abularrage, Giovanni B Torsello, Nabil Chakfe, John V White, Jos C VAN DEN Berg, Clark J Zeebregts, Nicola Troisi, Melina Vega DE Ceniga, Francesco Stilo, Mario D'Oria, Meghan Dermody, Piotr Myrcka, Katariina M Noronen, Jean-Baptiste Ricco, Hany Zayed, Michel J Bosiers, Robert A Morgan, Bruno Migliara, Caitlin W Hicks, Sherif A Sultan, Eric A Secemsky, Armando Mansilha, Michel M Reijnen, Hence J Verhagen, Mauro Gargiulo, Gianluca Faggioli, Guillaume Goudot, Domenico Valenti, Christian-Alexander Behrendt, Carlo Setacci, Alexei Svetlikov, Felice Pecoraro, Theodosios Bisdas, Andrej Schmidt, Arkadiusz Jawien, Csaba Csobay-Novak, Frank E Vermassen, Riikka Tulamo, Zoltan Szeberin, Bruce H Gray, Alessia Giaquinta, Jose Fernandes E Fernandes, Christos D Liapis, Vlad A Alexandrescu, Gaetano Lanza, Nuno V Dias, Diogo Cunha E Sa, Kak K Yeung, Piotr Musialek, Goncalo Cabral, Erwin Blessing, Gabor Menyhei, Robert C Lind, Ali Aburahma, Sean P Lyden, Marc L Schermerhorn, Frank J Veith","doi":"10.23736/S0392-9590.26.05593-8","DOIUrl":"10.23736/S0392-9590.26.05593-8","url":null,"abstract":"<p><strong>Background: </strong>Two recent multicenter randomized controlled trials (RCTs) compared best endovascular treatment versus surgical revascularization for patients with chronic limb-threatening ischemia (CLTI) and reached opposite conclusions. The aim of this international, expert-based Delphi Consensus document was to address these conflicting results and to explore their interpretation and applicability in the real-world clinical practice.</p><p><strong>Methods: </strong>A three-round Delphi Consensus document was completed by 51 European and 17 USA-based experts addressing five pre-specified CLTI clinical scenarios and two questions regarding the applicability of the two RCTs. All answers were provided anonymously. The response rate for each round was 100%. Consensus was reached when ≥70% of the participants agreed on a response showing preference for a specific approach.</p><p><strong>Results: </strong>Most participants (43/68; 63.3%) preferred a venous bypass for a patient with segmental occlusions of the lower limb arteries and an available distal target vessel, although this did not reach consensus. In contrast, consensus was achieved (49/68; 72.2%) for a diabetic patient with occlusion of all three infrapopliteal vessels for whom most experts favored angioplasty of any possible tibial artery. In case of previous endovascular recanalization failure, options were divided between repeat angioplasty (27 of 68; 39.7%) and venous bypass (35 of 68; 51.5%). The majority of participants reported that their approach had not changed following publication of the two RCTs (50 of 68; 73.5%) and did not believe that the trials had changed significantly the management of patients with CLTI in their clinical practice (53 of 68; 77.9%). In a subgroup analysis comparing European vs. USA-based physicians, there were minor differences in specific topics.</p><p><strong>Conclusions: </strong>In the present Expert-based Consensus document, considerable heterogeneity was found between USA-based and European participants on several topics related to CLTI and consensus was not always achieved. Endovascular and open surgical techniques should be regarded as complementary strategies, rather than as competing alternatives. Treatment should be individualized based on individual patient anatomy, extent of ischemia, presence of tissue loss, foot infection and conduit availability.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":"45 4","pages":"287-296"},"PeriodicalIF":1.8,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149069452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mariana Borges Firmo, Samantha Neves, Maria F Portugal, Viviane Santana DA Silva, Emanuel Firmo, Isabela Leal, Taina Ribeiro DE Azevedo, Fabricio Rodrigues Santiago, Walkiria Hueb Bernardi, Roberto A Caffaro, Eduardo Ramacciotti
{"title":"Impact of previous skin hydration on postsclerotherapy hyperpigmentation: a prospective, randomized, comparative study (SKINCARE Study).","authors":"Mariana Borges Firmo, Samantha Neves, Maria F Portugal, Viviane Santana DA Silva, Emanuel Firmo, Isabela Leal, Taina Ribeiro DE Azevedo, Fabricio Rodrigues Santiago, Walkiria Hueb Bernardi, Roberto A Caffaro, Eduardo Ramacciotti","doi":"10.23736/S0392-9590.26.05505-7","DOIUrl":"10.23736/S0392-9590.26.05505-7","url":null,"abstract":"<p><strong>Background: </strong>Postsclerotherapy hyperpigmentation (PSH) is a frequent and distressing complication. It is a cosmetic concern in aesthetic phlebology, with limited prospective efficacy/safety data. Skin hydration with moisturizer strengthens the skin barrier and may potentially prevent postsclerotherapy hyperpigmentation.</p><p><strong>Methods: </strong>This prospective, randomized, comparative study included 55 adult patients with reticular veins and telangiectasias. Patients were randomized to receive a daily moisturizer for 30 days before sclerotherapy or to no hydration. All participants underwent a single session of polidocanol 0.5% sclerotherapy. The primary efficacy outcome was moisturization's ability to prevent PSH, as evaluated by blinded evaluators using photos taken before and after procedures. Secondary outcomes included patient-reported outcomes assessed using the VEINES-QoL/Sym questionnaire.</p><p><strong>Results: </strong>Both groups experienced hyperpigmentation. PSH appeared in fewer patients who received hydration (44% vs. 57%, P=0.423), with no statistically significant difference. No skin alterations occurred at any time point. Nine patients (90%) rated the results as \"very good\" or \"excellent\".</p><p><strong>Conclusions: </strong>In this randomized, double-arm, prospective, pilot study, the use of moisturizer 30 days before polidocanol 0.5% sclerotherapy did not reduce PSH.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":"45 4","pages":"244-249"},"PeriodicalIF":1.8,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149069500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Álvaro Peñalba Vicario, Laura Yáñez García, Rodrigo Rial Horcajo, Andoni González Fernández, Iñaki Cernuda Artero, María R Vega Manrique
{"title":"Comparative cost analysis of saphenectomy and radiofrequency ablation in the treatment of great saphenous vein incompetence.","authors":"Álvaro Peñalba Vicario, Laura Yáñez García, Rodrigo Rial Horcajo, Andoni González Fernández, Iñaki Cernuda Artero, María R Vega Manrique","doi":"10.23736/S0392-9590.26.05519-7","DOIUrl":"10.23736/S0392-9590.26.05519-7","url":null,"abstract":"<p><strong>Background: </strong>The aim of this study was to assess the cost differences between two techniques for treating great saphenous vein incompetence: conventional surgerysaphenectomy and radiofrequency ablation.</p><p><strong>Methods: </strong>We conducted a retrospective observational cohort study, selecting 40 patients for the radiofrequency cohort and 80 for the saphenectomy cohort. Sociodemographic, baseline, clinical, and ultrasound follow-up data were collected at 10 days and one-month post-intervention. Finally, a cost analysis was performed from the perspective of both the public health system and society, with indirect costs related to sick leave evaluated in the latter perspective.</p><p><strong>Results: </strong>At the 10-day follow-up, hematoma incidence was significantly higher in the saphenectomy group (22 cases, 27.5% vs. 3 cases, 7.5%). The average Visual Analogue Scale pain score was higher in the radiofrequency group (2.1±1.8 vs. 1.1±1.7); however, mean analgesic consumption was higher in the saphenectomy group. From a cost perspective, the expense for the public health system was higher for radiofrequency (3167.2€ ± 123.4 vs. 3066.6€ ± 205.8). However, both sick leave costs (2276.6€ ± 1209.4 vs. 1105.8€ ± 1265.8) and total cost (5357.1€ ± 1246.1 vs. 4286.3€ ± 1294.8) were higher in the saphenectomy group.</p><p><strong>Conclusions: </strong>Radiofrequency ablation is a safe technique, allowing for an earlier return to normal work activities, with a low rate of complications and short- and medium-term efficacy at least equivalent to open surgery. The inclusion of radiofrequency ablation in our health system may yield overall cost savings compared to saphenectomy in the surgical treatment of great saphenous vein incompetence.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":"45 4","pages":"250-258"},"PeriodicalIF":1.8,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149069495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kosmas I Paraskevas, Mahmoud B Malas, Armando Mansilha, Ali F Aburahma
{"title":"The randomized controlled trials on the management of asymptomatic carotid patients may be misleading: it is all about carotid plaque morphology, not the percentage of asymptomatic carotid artery stenosis.","authors":"Kosmas I Paraskevas, Mahmoud B Malas, Armando Mansilha, Ali F Aburahma","doi":"10.23736/S0392-9590.26.05584-7","DOIUrl":"https://doi.org/10.23736/S0392-9590.26.05584-7","url":null,"abstract":"","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":"45 4","pages":"241-243"},"PeriodicalIF":1.8,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149069433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zhen Ma, Yan Zhang, Xiao Liu, Wei Wang, Jingliang Gu, Tao Feng, Lina Ma
{"title":"Predictive value of Ankle-Brachial Index variability for symptom progression in peripheral arterial disease: a prospective cohort study.","authors":"Zhen Ma, Yan Zhang, Xiao Liu, Wei Wang, Jingliang Gu, Tao Feng, Lina Ma","doi":"10.23736/S0392-9590.26.05512-4","DOIUrl":"https://doi.org/10.23736/S0392-9590.26.05512-4","url":null,"abstract":"<p><strong>Background: </strong>The ankle-brachial index (ABI) is an important indicator for assessing the severity of peripheral arterial disease (PAD), but the limitations of single measurements are increasingly recognized. This study aimed to explore the predictive value of diurnal ABI variability for PAD symptom progression and to develop a prediction model incorporating ABI variability.</p><p><strong>Methods: </strong>This prospective cohort study enrolled patients diagnosed with PAD, stratified by Fontaine staging. All patients underwent ABI measurements at three time points (8:00, 12:00, 18:00) at baseline, with calculation of ABI mean, range, and coefficient of variation. The primary endpoint was symptom progression during follow-up. Generalized additive models (GAM) were used to evaluate the relationship between ABI variability and symptom progression, with comparison to restricted cubic splines (RCS) and linear models.</p><p><strong>Results: </strong>The final analysis included 680 PAD patients followed for 40 months, with 225 (33.1%) experiencing symptom progression. Diurnal ABI variability (range, standard deviation, and coefficient of variation) showed differences between progression and non-progression groups, but these were not statistically significant (P=0.079). GAM modeling revealed that age (P<0.001) and mean ABI (P=0.032) were significant predictors of symptom progression, while ABI range alone was not significant as a predictor (P=0.214). The model demonstrated good calibration (Hosmer-Lemeshow Test P=0.1327) and moderate discrimination (AUC=0.688, 95%CI: 0.643-0.733). Patients were stratified into three risk groups based on predicted risk: low-risk (≤18%), medium-risk (19-29%), and high-risk (≥30%), with actual event rates of 13.2%, 23.7%, and 36.8%, respectively, showing good agreement with predicted risks. Kaplan-Meier analysis revealed significant differences in progression-free survival when stratified by ABI severity (P=0.013), but not when stratified by ABI variability (P=0.79).</p><p><strong>Conclusions: </strong>Mean ABI and age are the primary predictors of PAD symptom progression, while diurnal ABI variability may provide additional predictive value in specific patient subgroups. Prediction models incorporating multiple time-point ABI measurements facilitate risk stratification and individualized management of PAD patients.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":"45 4","pages":"267-286"},"PeriodicalIF":1.8,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149069493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Sharp needle recanalization for dialysis access occlusion: a single-center retrospective study.","authors":"Hua-Ming Cheng, Reng-Hong Wu, Chien-Chuan Huang, Jyun-Yan Liou","doi":"10.23736/S0392-9590.26.05502-1","DOIUrl":"https://doi.org/10.23736/S0392-9590.26.05502-1","url":null,"abstract":"<p><strong>Background: </strong>Long-term patency of arteriovenous fistulas (AVFs) is critical for hemodialysis patients. Sharp needle recanalization (SNR) is an image-guided percutaneous technique employed when conventional recanalization methods fail. This study evaluated the effectiveness of SNR in maintaining AVF patency.</p><p><strong>Methods: </strong>We conducted a retrospective analysis of patients who underwent SNR for AVF occlusion between July 2014 and June 2023. Outcomes included technical success, assisted technical success, and patency rates (primary, assisted primary, and secondary). Complications and patient survival were assessed, with patency estimated using Kaplan-Meier analysis.</p><p><strong>Results: </strong>Thirty-three patients were included. Technical success was achieved in 79% of cases, while assisted technical success reached 100%. Primary patency decreased from 48% at 3 months to 9% at 24 months. Assisted primary patency was 73% at 3 months and 27% at 24 months. Secondary patency was highest, stabilizing at 71% at 24 months. Thrombosis occurred in 27% of patients, and 24% required creation of a new access tract. Nine patients died during follow-up, none related to the procedure.</p><p><strong>Conclusions: </strong>SNR is an effective salvage option for AVF occlusion, offering durable secondary patency. The steep decline in primary patency underscores the importance of vigilant follow-up and timely reintervention to preserve dialysis access.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":"45 4","pages":"297-303"},"PeriodicalIF":1.8,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149069496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
International AngiologyPub Date : 2026-08-01Epub Date: 2026-07-07DOI: 10.23736/S0392-9590.26.05541-0
Julie Krogh Pedersen, Ulver Spangsberg Rouw, Rebecca A Conradsen Skov, Laurence Rouet, Jonas P Eiberg, Qasam M Ghulam
{"title":"Lower intraluminal thrombus load in patients with abdominal aortic aneurysms and blood type O.","authors":"Julie Krogh Pedersen, Ulver Spangsberg Rouw, Rebecca A Conradsen Skov, Laurence Rouet, Jonas P Eiberg, Qasam M Ghulam","doi":"10.23736/S0392-9590.26.05541-0","DOIUrl":"10.23736/S0392-9590.26.05541-0","url":null,"abstract":"<p><strong>Background: </strong>Abdominal aortic aneurysm (AAA) is a major cause of mortality among older men. Current clinical practice primarily determines the indication for elective AAA repair based on the maximum aneurysm diameter. However, this approach may not adequately capture the complexity of individual rupture risk, and intraluminal thrombus (ILT) has been associated with increased growth and rupture risk. In other vascular beds, non-O blood types are correlated with an increased risk of thrombosis. This study investigates the association between ABO blood type and ILT volume in AAA patients.</p><p><strong>Methods: </strong>A cross-sectional analysis of patients with infrarenal AAAs from the Copenhagen Aortic Cohort (COACH) assessed AAA diameter, AAA volume, and ILT volume using three-dimensional ultrasound and 3D-CEUS, respectively. Patients were categorized into blood type O and non-O groups for analysis. ILT volume was compared between the groups.</p><p><strong>Results: </strong>In total, 296 patients under surveillance for AAA with a median AP diameter of 43 [IQR 38-48] mm, and blood type O (N.=101) and non-O (N.=195) were included. Patients with blood type O had a 4.6% lower ILT volume per 10 mL AAA volume than patients with other blood-types (P=0.003), after adjusting for AAA volume and other known covariates.</p><p><strong>Conclusions: </strong>Blood type O is associated with a lower thrombus load in patients with AAA. This finding aligns with prior evidence linking non-O blood types to elevated vWf and Factor VIII levels, both important in generating thromboses. Future longitudinal studies are needed to explore the relationship between blood type and AAA progression.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":" ","pages":"259-266"},"PeriodicalIF":1.8,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148396169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}